USD906513S1 - Pill - Google Patents

Pill Download PDF

Info

Publication number
USD906513S1
USD906513S1 US29/684,226 US201929684226F USD906513S US D906513 S1 USD906513 S1 US D906513S1 US 201929684226 F US201929684226 F US 201929684226F US D906513 S USD906513 S US D906513S
Authority
US
United States
Prior art keywords
pill
view
perspective
ornamental design
another embodiment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/684,226
Inventor
Martin Asmussen
Mette Høg Gaunø
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US29/684,226 priority Critical patent/USD906513S1/en
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority to JPD2019-500333F priority patent/JP1694516S/ja
Priority to JPD2019-500327F priority patent/JP1694514S/ja
Priority to JPD2019-500332F priority patent/JP1694513S/ja
Priority to JPD2019-500334F priority patent/JP1694517S/ja
Priority to JPD2019-500328F priority patent/JP1694515S/ja
Assigned to NOVO NORDISK A/S reassignment NOVO NORDISK A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASMUSSEN, MARTIN, GAUNØ, METTE HØG
Priority to US29/760,683 priority patent/USD947358S1/en
Application granted granted Critical
Publication of USD906513S1 publication Critical patent/USD906513S1/en
Priority to US29/826,108 priority patent/USD1039677S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a top perspective view of a pill showing our new design;
FIG. 2 is a bottom perspective view thereof;
FIG. 3 is a front view thereof;
FIG. 4 is a rear view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a right side view thereof;
FIG. 7 is a top view thereof;
FIG. 8 is a bottom view thereof;
FIG. 9 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7;
FIG. 10 is a bottom view thereof;
FIG. 11 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7; and,
FIG. 12 is a bottom view thereof.

Claims (1)

    CLAIM
  1. The ornamental design for a pill, as shown and described.
US29/684,226 2019-03-19 2019-03-19 Pill Active USD906513S1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US29/684,226 USD906513S1 (en) 2019-03-19 2019-03-19 Pill
JPD2019-500327F JP1694514S (en) 2019-03-19 2019-04-16
JPD2019-500332F JP1694513S (en) 2019-03-19 2019-04-16
JPD2019-500334F JP1694517S (en) 2019-03-19 2019-04-16
JPD2019-500333F JP1694516S (en) 2019-03-19 2019-04-16
JPD2019-500328F JP1694515S (en) 2019-03-19 2019-04-16
US29/760,683 USD947358S1 (en) 2019-03-19 2020-12-03 Pill
US29/826,108 USD1039677S1 (en) 2019-03-19 2022-02-09 Pill

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/684,226 USD906513S1 (en) 2019-03-19 2019-03-19 Pill

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US29/760,683 Continuation USD947358S1 (en) 2019-03-19 2020-12-03 Pill

Publications (1)

Publication Number Publication Date
USD906513S1 true USD906513S1 (en) 2020-12-29

Family

ID=74041278

Family Applications (3)

Application Number Title Priority Date Filing Date
US29/684,226 Active USD906513S1 (en) 2019-03-19 2019-03-19 Pill
US29/760,683 Active USD947358S1 (en) 2019-03-19 2020-12-03 Pill
US29/826,108 Active USD1039677S1 (en) 2019-03-19 2022-02-09 Pill

Family Applications After (2)

Application Number Title Priority Date Filing Date
US29/760,683 Active USD947358S1 (en) 2019-03-19 2020-12-03 Pill
US29/826,108 Active USD1039677S1 (en) 2019-03-19 2022-02-09 Pill

Country Status (1)

Country Link
US (3) USD906513S1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD947358S1 (en) * 2019-03-19 2022-03-29 Novo Nordisk A/S Pill
USD983481S1 (en) * 2021-11-10 2023-04-18 Helikon Gida Sanayi Ve Ticaret Limited Sirketi Chewing gum
USD1071139S1 (en) * 2023-03-13 2025-04-15 Kenvue Brands Llc Dosage form
USD1120291S1 (en) * 2024-05-30 2026-03-24 Novo Nordisk A/S Pill

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998009585A1 (en) 1996-09-05 1998-03-12 Kelman Charles D High myopia anterior chamber lens with anti-glare mask
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
USD434846S (en) * 1999-07-07 2000-12-05 Merck & Co., Inc. Tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD475451S1 (en) * 2002-09-09 2003-06-03 Access Business Group International Llc Vitamin tablet
USD535021S1 (en) * 2005-04-22 2007-01-09 Wm. Wrigley Jr. Company Elliptical tablet
JP2011058602A (en) 2009-09-14 2011-03-24 Jtekt Corp Deflective meshing type gear device
USD636865S1 (en) * 2010-08-25 2011-04-26 KVK-Tech, Inc. Pharmaceutical tablet
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD787042S1 (en) * 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787043S1 (en) * 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4401456A1 (en) 1994-01-19 1995-07-20 Wissenschaftsfoerderung Der De Process for clarifying beer using crossflow microfiltration
AU132520S (en) * 1996-11-28 1997-12-19 Astra Ab Tablet
ES2226128T3 (en) * 1997-06-11 2005-03-16 THE PROCTER & GAMBLE COMPANY COMPRESSED COVERED WITH A FILM FOR IMPROVED SUPERIOR GASTROINTESTINAL TRACT SECURITY.
USD430285S (en) * 1999-04-16 2000-08-29 Merck & Co., Inc. Tablet
USD564086S1 (en) * 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
USD671636S1 (en) * 2010-04-23 2012-11-27 Daiichi Sankyo Company, Limited Pharmaceutical tablet
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD907760S1 (en) * 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
USD835257S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998009585A1 (en) 1996-09-05 1998-03-12 Kelman Charles D High myopia anterior chamber lens with anti-glare mask
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
USD434846S (en) * 1999-07-07 2000-12-05 Merck & Co., Inc. Tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD475451S1 (en) * 2002-09-09 2003-06-03 Access Business Group International Llc Vitamin tablet
USD535021S1 (en) * 2005-04-22 2007-01-09 Wm. Wrigley Jr. Company Elliptical tablet
JP2011058602A (en) 2009-09-14 2011-03-24 Jtekt Corp Deflective meshing type gear device
USD636865S1 (en) * 2010-08-25 2011-04-26 KVK-Tech, Inc. Pharmaceutical tablet
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD787042S1 (en) * 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787043S1 (en) * 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835258S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Ingenioren ("The Engineer"), "Tabletter mod diabetes abner helt ny aura for Novo Nordisk," May 18, 2018, <https://ing.dk/artikel/tabletter-mod-diabetes-aabner-helt-ny-aera-novo-nordisk-212236>, visited on Mar. 3, 2019.
Medwatch, "Novo Nordisk chases competitive edge with new version of GLP-1 tablet," Sep. 19, 2018, <https://medwatch.dk/secure/Top_picks_ in_english/article10874729.ece>.

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD947358S1 (en) * 2019-03-19 2022-03-29 Novo Nordisk A/S Pill
USD1039677S1 (en) 2019-03-19 2024-08-20 Novo Nordisk A/S Pill
USD1120290S1 (en) * 2020-05-13 2026-03-24 Eli Lilly And Company Pharmaceutical tablet
USD983481S1 (en) * 2021-11-10 2023-04-18 Helikon Gida Sanayi Ve Ticaret Limited Sirketi Chewing gum
USD1071139S1 (en) * 2023-03-13 2025-04-15 Kenvue Brands Llc Dosage form
USD1120291S1 (en) * 2024-05-30 2026-03-24 Novo Nordisk A/S Pill

Also Published As

Publication number Publication date
USD1039677S1 (en) 2024-08-20
USD947358S1 (en) 2022-03-29

Similar Documents

Publication Publication Date Title
USD980625S1 (en) Case
USD990356S1 (en) Necklace
USD990358S1 (en) Necklace
USD960753S1 (en) Necklace
USD962108S1 (en) Necklace
USD958686S1 (en) Bracelet
USD945906S1 (en) Necklace
USD960746S1 (en) Necklace
USD945905S1 (en) Necklace
USD935931S1 (en) Necklace
USD957979S1 (en) Necklace
USD935930S1 (en) Necklace
USD934719S1 (en) Necklace
USD941697S1 (en) Necklace
USD946447S1 (en) Necklace
USD959319S1 (en) Bracelet
USD910008S1 (en) Tablet computer
USD896233S1 (en) Tablet case
USD934720S1 (en) Necklace
USD871415S1 (en) Tablet case
USD911020S1 (en) Pill organizer
USD903521S1 (en) Bracelet
USD920097S1 (en) Capsule
USD959284S1 (en) Packaging
USD852039S1 (en) Container

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY